Stock A086900 MEDY-TOX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Medy-Tox Inc.

Equities

A086900

KR7086900008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
132,200 KRW +1.15% Intraday chart for Medy-Tox Inc. +3.20% -45.15%
Mar. 21 Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 05 South Korean Shares Close Marginally Lower on North Korea's Artillery Shells Firing MT

Chart calendar Medy-Tox Inc.

95fe9212da163f4.Tt3NopfPPsaHPDcNtdoWcHTcPZC0cNr8BKLU_GQAPL4.Pq34-u2gcLXtdl587b9DCjXrD-XDG66zPfa8hhVjfYt7mY76079fjehmBw~b5cd2fefe9e30a64a9ebb51a35e34e7e

Upcoming events on Medy-Tox Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-24 Q4 2024 Earnings Release (Projected)

Past events on Medy-Tox Inc.

2024-03-20 Q4 2023 Earnings Release
2023-11-07 Q3 2023 Earnings Release
2023-08-06 Q2 2023 Earnings Release
2023-05-14 Q1 2023 Earnings Release
2023-03-20 Q4 2022 Earnings Release
2022-11-13 Q3 2022 Earnings Release
2022-08-11 Interim 2022 Earnings Release
2022-05-15 Q1 2022 Earnings Release
2022-03-22 FY 2021 Earnings Release
2021-08-12 Interim 2021 Earnings Release
2021-05-16 Q1 2021 Earnings Release
2021-03-22 FY 2020 Earnings Release
2020-03-29 FY 2019 Earnings Release
2019-11-13 Q3 2019 Earnings Release
2019-05-14 Q1 2019 Earnings Release
2018-08-13 Interim 2018 Earnings Release
2018-02-13 FY 2017 Earnings Release

Past dividends on Medy-Tox Inc.

2023-09-25 Interim Payment 1100 KRW
2022-09-28 Interim Payment 1000 KRW
2021-09-28 Interim Payment 1000 KRW
2020-09-27 Interim Payment 1000 KRW
2019-09-26 Interim Payment 800 KRW
2018-09-26 Interim Payment 900 KRW
2017-12-26 Final Payment 1400 KRW
2017-09-27 Interim Payment 800 KRW
2016-12-27 Final Payment 1300 KRW
2016-09-28 Interim Payment 700 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		206
203
1.29%		141
141
-0.33%		185
181
1.95%		195
192
1.41%		221
220
0.48%
252

EBITDA
Billions KRW		Released
Forecast
Spread 		44,3
63,3
-30.02%		-19,1
-19,0
-0.48%		51,9
47,2
9.82%		62,0
52,9
17.06%		32,7
42,4
-22.91%
71,0

EBIT
Billions KRW		Released
Forecast
Spread 		25,7
44,7
-42.47%		-37,1
-38,8
4.56%		34,5
37,3
-7.65%		46,7
37,9
23.01%		17,3
29,9
-41.98%
54,6

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		25,1
43,6
-42.27%		-42,1
-30,2
-39.61%		129
152
-14.7%		49,3
62,6
-21.26%		15,7
34,4
-54.21%
55,8

Net income
Billions KRW		Released
Forecast
Spread 		26,2
38,8
-32.51%		-29,0
-23,0
-25.99%		96,2
110
-12.76%		37,6
49,2
-23.67%		9,64
24,6
-60.82%
43,4

EPS
KRW		Released
Forecast
Spread 		4 172
5 907
-29.37%		-4 841
-3 438
-40.8%		15 243
17 115
-10.94%		5 750
5 629
2.16%		1 311
3 634
-63.93%
6 336

Announcement Date04/03/2012/03/2111/03/2207/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Billions KRW		Released
Forecast
Spread 		45,7
41,4
10.2%		39,8


49,8
46,0
8.1%		53,3
46,3
15.14%		52,3
51,4
1.76%		42,7
48,4
-11.83%		51,8
53,5
-3.2%		58,7
56,7
3.4%		68,0
66,9
1.59%
59,7


58,6


61,8


70,1

EBIT
Billions KRW		Released
Forecast
Spread 		0,56
3,42
-83.58%


10,4
8,09
28.28%		14,5
8,59
69.1%		16,3
13,0
25.66%		1,77
11,5
-84.63%		9,55
11,7
-18.13%		3,58
10,7
-66.43%		2,43
15,0
-83.85%
9,60


11,8


15,2


18,1

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		-19,7
4,85
-505.96%


24,2
8,40
188.37%		17,6
8,50
106.91%		2,31
15,0
-84.57%


9,15
8,90
2.83%		3,43
12,0
-71.31%		-3,38
10,2
-133.09%
11,0


12,2


14,9


18,1

Net income
Billions KRW		Released
Forecast
Spread 		-107
3,23
-3420.45%


19,2
6,15
212.75%		13,2
8,25
60.1%		-0,57
11,8
-104.83%


8,98
7,10
26.46%		-2,32
9,55
-124.32%		12,1
8,80
37.24%
8,40


9,30


11,4


13,9

EPS
KRW		Released
Forecast
Spread


639



































Announcement Date11/03/2216/05/2212/08/2209/11/2207/03/2315/05/2307/08/2308/11/2307/03/24----

Upcoming sector events for Medy-Tox Inc.

Today 02:00 am BONESUPPORT HOLDING AB: Q1 2024 Earnings Release
Today 02:00 am SWEDISH ORPHAN BIOVITRUM AB: Q1 2024 Earnings Release
2024-04-25 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
2024-04-25 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
2024-04-25 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release
2024-04-25 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.: Q1 2024 Earnings Release
2024-04-25 ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
More events

Past sector events for Medy-Tox Inc.

Today CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.: Q1 2024 Earnings Release (Projected)
Today JIANGSU AIDEA PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
Today GAN & LEE PHARMACEUTICALS.: Q1 2024 Earnings Release
Today GAN & LEE PHARMACEUTICALS.: Q4 2023 Earnings Release
Today WALVAX BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release
Today CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release (Projected)
Today BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q1 2024 Earnings Release (Projected)
Today PHARMA MAR, S.A.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A086900 Stock
  4. Calendar Medy-Tox Inc.